Veenat 400mg Imatinib Tablet

Veenat 400mg Imatinib Tablet is a prescription targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GISTs), and certain other cancers. It contains Imatinib, a tyrosine kinase inhibitor (TKI) that works by blocking specific proteins responsible for the growth and multiplication of cancer cells. By targeting these abnormal cellular pathways, Veenat 400mg Imatinib Tablet helps slow disease progression and supports long-term cancer management. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to assess treatment response and manage potential side effects. Patients should use Veenat 400mg Imatinib Tablet only as prescribed by their healthcare provider and attend all recommended follow-up appointments during treatment.